Congenital heart disease

Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease. A scientific statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the ESC Working Group on Adult Congenital Heart Disease, and the Association of Cardiovascular Nursing & Allied Professions of the ESC

Eur J Heart FailPublished Scientific statement

Recommendations

As issued by the authors

  1. PAH risk stratification models, mainly derived from idiopathic PAH cohorts, are not automatically applicable to all PAH-CHD, especially Eisenmenger syndrome

  2. Shunt location, congenital heart disease (CHD) complexity, degree of cyanosis, iron deficiency, syndromic co-morbidity and biomarkers other than BNP may play an important role in prognostication

Original publication

Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease. A scientific statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the ESC Working Group on Adult Congenital Heart Disease, and the Association of Cardiovascular Nursing & Allied Professions of the ESC. Eur J Heart Fail. Published 9 March 2026. doi:10.1093/ejhf/xuag059

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.